BASTIDE LE CONFORT MEDICAL (BLC.PA) Stock Fundamental Analysis
Europe - EPA:BLC - FR0000035370 - Common Stock
25.7 EUR
-0.15 (-0.58%)
Taking everything into account, BLC scores 4 out of 10 in our fundamental rating. BLC was compared to 27 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of BLC while its profitability can be described as average. BLC has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year BLC was profitable.
BLC had a positive operating cash flow in the past year.
BLC had positive earnings in 4 of the past 5 years.
BLC had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
With a Return On Assets value of 0.25%, BLC is not doing good in the industry: 77.78% of the companies in the same industry are doing better.
With a Return On Equity value of 2.25%, BLC is not doing good in the industry: 70.37% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 5.65%, BLC is in the better half of the industry, outperforming 62.96% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BLC is in line with the industry average of 6.10%.
The 3 year average ROIC (5.34%) for BLC is below the current ROIC(5.65%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROIC | 5.65% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
1.3 Margins
BLC has a worse Profit Margin (0.32%) than 74.07% of its industry peers.
BLC's Operating Margin of 7.67% is in line compared to the rest of the industry. BLC outperforms 59.26% of its industry peers.
In the last couple of years the Operating Margin of BLC has grown nicely.
BLC has a Gross Margin of 67.54%. This is in the better half of the industry: BLC outperforms 74.07% of its industry peers.
BLC's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% |
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
2. Health
2.1 Basic Checks
BLC has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
Compared to 1 year ago, BLC has less shares outstanding
Compared to 5 years ago, BLC has more shares outstanding
The debt/assets ratio for BLC has been reduced compared to a year ago.
2.2 Solvency
Based on the Altman-Z score of 1.39, we must say that BLC is in the distress zone and has some risk of bankruptcy.
BLC has a Altman-Z score of 1.39. This is in the lower half of the industry: BLC underperforms 62.96% of its industry peers.
BLC has a debt to FCF ratio of 9.33. This is a negative value and a sign of low solvency as BLC would need 9.33 years to pay back of all of its debts.
BLC has a Debt to FCF ratio (9.33) which is comparable to the rest of the industry.
A Debt/Equity ratio of 5.20 is on the high side and indicates that BLC has dependencies on debt financing.
The Debt to Equity ratio of BLC (5.20) is worse than 88.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Altman-Z | 1.39 |
ROIC/WACC1.2
WACC4.72%
2.3 Liquidity
BLC has a Current Ratio of 1.19. This is a normal value and indicates that BLC is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.19, BLC perfoms like the industry average, outperforming 55.56% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that BLC may have some problems paying its short term obligations.
The Quick ratio of BLC (0.96) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
BLC shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -71.43%.
BLC shows a small growth in Revenue. In the last year, the Revenue has grown by 3.24%.
The Revenue has been growing by 9.55% on average over the past years. This is quite good.
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
3.2 Future
BLC is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.08% yearly.
BLC is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.06% yearly.
EPS Next Y-4.84%
EPS Next 2Y7.02%
EPS Next 3Y6.08%
EPS Next 5YN/A
Revenue Next Year5.64%
Revenue Next 2Y5.76%
Revenue Next 3Y5.74%
Revenue Next 5Y5.06%
3.3 Evolution
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 116.82, BLC can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of BLC indicates a slightly more expensive valuation: BLC is more expensive than 77.78% of the companies listed in the same industry.
BLC is valuated expensively when we compare the Price/Earnings ratio to 27.30, which is the current average of the S&P500 Index.
BLC is valuated reasonably with a Price/Forward Earnings ratio of 8.61.
Based on the Price/Forward Earnings ratio, BLC is valued cheaper than 96.30% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.73, BLC is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 116.82 | ||
| Fwd PE | 8.61 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, BLC is valued cheaper than 85.19% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, BLC is valued a bit cheaper than 77.78% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.2 | ||
| EV/EBITDA | 5.75 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.02%
EPS Next 3Y6.08%
5. Dividend
5.1 Amount
No dividends for BLC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
EPA:BLC (9/12/2025, 7:00:00 PM)
25.7
-0.15 (-0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners9.28%
Inst Owner ChangeN/A
Ins Owners1.58%
Ins Owner ChangeN/A
Market Cap189.41M
Analysts83.33
Price Target36.72 (42.88%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly Dividend0.22
Dividend Growth(5Y)-3.5%
DP42.86%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)9.09%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-13.25%
EPS NY rev (3m)-13.25%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.4%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 116.82 | ||
| Fwd PE | 8.61 | ||
| P/S | 0.35 | ||
| P/FCF | 4.2 | ||
| P/OCF | 1.69 | ||
| P/B | 2.49 | ||
| P/tB | N/A | ||
| EV/EBITDA | 5.75 |
EPS(TTM)0.22
EY0.86%
EPS(NY)2.98
Fwd EY11.61%
FCF(TTM)6.12
FCFY23.81%
OCF(TTM)15.22
OCFY59.2%
SpS73.31
BVpS10.32
TBVpS-19.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.25% | ||
| ROE | 2.25% | ||
| ROCE | 8.61% | ||
| ROIC | 5.65% | ||
| ROICexc | 5.65% | ||
| ROICexgc | 10.3% | ||
| OM | 7.67% | ||
| PM (TTM) | 0.32% | ||
| GM | 67.54% | ||
| FCFM | 8.35% |
ROA(3y)1.29%
ROA(5y)1.7%
ROE(3y)9.6%
ROE(5y)12.13%
ROIC(3y)5.34%
ROIC(5y)5.17%
ROICexc(3y)5.7%
ROICexc(5y)5.58%
ROICexgc(3y)12.68%
ROICexgc(5y)11.8%
ROCE(3y)8.16%
ROCE(5y)7.93%
ROICexcg growth 3Y11.16%
ROICexcg growth 5Y1.85%
ROICexc growth 3Y8.09%
ROICexc growth 5Y5.81%
OM growth 3Y3.59%
OM growth 5Y6.18%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y12.18%
GM growth 5Y6.9%
F-Score6
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 5.2 | ||
| Debt/FCF | 9.33 | ||
| Debt/EBITDA | 3.72 | ||
| Cap/Depr | 103.59% | ||
| Cap/Sales | 12.41% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 105.61% | ||
| Profit Quality | 2640.05% | ||
| Current Ratio | 1.19 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | 1.39 |
F-Score6
WACC4.72%
ROIC/WACC1.2
Cap/Depr(3y)89.47%
Cap/Depr(5y)88.81%
Cap/Sales(3y)10.8%
Cap/Sales(5y)10.65%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-71.43%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%130.77%
EPS Next Y-4.84%
EPS Next 2Y7.02%
EPS Next 3Y6.08%
EPS Next 5YN/A
Revenue 1Y (TTM)3.24%
Revenue growth 3Y6.06%
Revenue growth 5Y9.55%
Sales Q2Q%3.96%
Revenue Next Year5.64%
Revenue Next 2Y5.76%
Revenue Next 3Y5.74%
Revenue Next 5Y5.06%
EBIT growth 1Y3.82%
EBIT growth 3Y9.86%
EBIT growth 5Y16.32%
EBIT Next Year166.67%
EBIT Next 3Y44.23%
EBIT Next 5YN/A
FCF growth 1Y197.72%
FCF growth 3Y10.22%
FCF growth 5Y6.95%
OCF growth 1Y63.86%
OCF growth 3Y7.62%
OCF growth 5Y8.72%